Skip to content 
Harvard Pulmonary and Critical Care Medicine 2024
Comprehensive Updates for State-of-the-Art Care: Evaluation, Diagnosis, Treatment, Procedures and Challenging Cases
Pulmonary and Critical Care Medicine will be held online this year, using live streaming, electronic Q&A, and other remote learning technologies. The 2024 program will be highly interactive, providing opportunities throughout the program to pose questions online to nationally and internationally recognized leaders in their respective areas of pulmonary and critical care medicine.
OVERVIEW
This comprehensive course provides education and updates to optimize your care of patients with:
- Sepsis
- ARDS
- Sarcoidosis
- IPF
- Bronchiectasis
- Cystic fibrosis
- Lung nodules
- Lung cancer
- GERD
- Pleural disease
- Pneumonia
- Tuberculosis
- Thromboembolism
- Chronic cough
- COPD
- Asthma
- Occupational and environmental lung disease
- Interstitial lung disease
- Lung transplantation
- Neurologic issues in the ICU
- Sleep-disordered breathing
- Post-acute sequelae of COVID-19
- Surgical emergencies
- Atypical mycobacterial disease
- Pulmonary hypertension
- Cardiopulmonary disorders
- Complications from cardiac arrest
- Hypersensitivity pneumonitis
- Acute respiratory failure
REASONS TO ATTEND IN 2024
All sessions are led by master clinicians who deliver information in inspiring and entertaining ways, and provide specific recommendations to incorporate the latest updates into your practice. Education covers:
- The most current guidelines for treating sepsis
- Evidence-based treatment of ARDS
- State of the art in interventional pulmonology
- High-flow oxygen therapy for respiratory failure
- Updates on biologics in asthma and other lung disease
- New concepts in the use of vasopressors in septic shock
- New drugs and combinations in pulmonary hypertension
- New evidence on sedation, analgesia, and early mobility
- Point-of-care pulmonary ultrasound in the intensive care unit
- Lung microbiome: emerging implications for lung health
- Emerging evidence for targeted temperature management
- Evaluating occupational and environmental lung disease
- Steroid-sparing agents for interstitial lung disease
- Pulmonary embolus: the latest treatment strategies
- State-of-the-art management of the critically ill patient
- Guidance to conduct end-of-life discussions
- Updates in pulmonary pathology
- New treatment options in cystic fibrosis
- Handling neurologic and surgical emergencies in the medical ICU
- New approaches that improve outcomes for patients with unexplained chronic cough
Dr. Luis Ramirez, Pulmonary and Critical Care Attending –
"As someone who's been practicing for over 20 years, I was amazed by the breadth of innovative diagnostic tools, treatment modalities, and care protocols covered in this conference. The faculty seamlessly blended the latest research with real-world clinical pearls. A must-attend for pulmonary and critical care professionals of all experience levels."
Dr. Amelia Flores, Chief of Gastroenterology –
"This conference single-handedly reignited my passion for gastroenterology. The innovative research, cutting-edge therapies, and emphasis on holistic patient care have inspired me to think more creatively about GI disease management. Bravo to the Harvard team for organizing such an exceptional event!"
Dr. Michael Hernandez, Critical Care Fellow –
"This conference quite literally transformed my approach to managing complex respiratory conditions like ARDS and pulmonary hypertension. The faculty's depth of expertise and commitment to practical, patient-centered care was truly inspiring. I highly recommend this program to any pulmonary or critical care specialist."
Dr. Olivia Nguyen, Respiratory Therapist –
"Harvard has raised the bar with this comprehensive review course. From the meticulously organized agenda to the state-of-the-art simulation labs, every aspect of this program was designed to maximize my learning."